| Financial Year |
March 31 2023 |
| Monetary Funds |
4,023,104,065.96 |
| Held-for-trading Financial Assets |
1,551,633,461.06 |
| Notes Receivable |
-- |
| Accounts Receivable |
726,971,996.19 |
| Advances to Suppliers |
64,986,244.32 |
| Other Receivables |
423,160,133.67 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
12,469,325,879.56 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
234,794,787.71 |
| Total Current Assets |
19,687,694,512.91 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
908,287,339.36 |
| Investment Properties |
16,985,679,688.87 |
| Fixed Assetes |
777,342,088.43 |
| Under-construction Projects |
1,278,263.52 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
215,681,767.53 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
77,501,987.71 |
| Deferred Income Tax Assets |
639,028,042.59 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
20,715,898,523.40 |
| Total Assets |
40,403,593,036.31 |
| Short-Term Loans |
7,481,522,330.27 |
| Trading Financial liabilities |
-- |
| Notes Payable |
96,538,581.26 |
| Accounts Payable |
2,366,209,772.77 |
| Accounts Received In Advance |
139,526,565.48 |
| Employee Compensation Payable |
139,773,806.97 |
| Taxes Payable |
1,962,827,004.88 |
| Interest Payable |
-- |
| Dividend Payable |
1,340,216.94 |
| Other payables |
1,002,359,207.48 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,298,254,807.55 |
| Other Current Liabilities |
486,514.36 |
| Sub-Total of Current Liabilities |
20,734,845,703.44 |
| Long-term Loans |
1,824,862,685.78 |
| Bonds Payable |
4,495,983,833.33 |
| Long-Term Accounts Payable |
704,280,735.45 |
| Special Payable |
-- |
| Estimatied Liabilities |
47,617,098.30 |
| Deferred Income Tax Liabilities |
2,125,071.28 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
7,338,370,121.12 |
| Total Liabilities |
28,073,215,824.56 |
| Paid-In Capital(Or Share Stock) |
1,135,349,124.00 |
| Capital Surplus |
3,589,363,337.86 |
| Surplus Reserve |
1,017,853,923.86 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
6,264,921,520.03 |
| Minority Stockholder's Interest |
304,755,394.42 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
12,025,621,817.33 |
| Owner's Equity（Stockholder's Equity） |
12,330,377,211.75 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
40,403,593,036.31 |
